Carbocysteines in the current therapy of lung diseases in children
The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical a...
Main Author: | Yu. L. Mizernitsky |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2016-11-01
|
Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
Subjects: | |
Online Access: | https://www.ped-perinatology.ru/jour/article/view/374 |
Similar Items
-
Mucoactive drugs
by: R. Balsamo, et al.
Published: (2010-06-01) -
The relevance of the application mukoactive preparations in patients with inflammatory pathology of ent organs
by: V. M. Svistushkin, et al.
Published: (2018-11-01) -
CARBOCYSTEINE LYSINE SALT MONOHYDRATE IN TREATMENT OF DISEASES OF LOWER RESPIRATORY TRACT IN CHILDREN
by: T. A. Kruchkova
Published: (2013-12-01) -
EUGENOL POLYMER MODIFIED TITANIUM ELECTRODE FOR THE ANALYSIS OF CARBOCYSTEINE
by: S. EL QOUATLI, et al.
Published: (2012-06-01) -
CLINICAL AND IMMUNOLOGICAL EFFECTS OF CARBOCYSTEINE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. G. Shuganov, et al.
Published: (2016-02-01)